# Fasting insulin and HOMA-IR: what the numbers can tell you

HOMA-IR estimates insulin resistance from fasting glucose and insulin. Learn what it measures and how it differs from diabetes testing.

Canonical: https://velri.co/blog/fasting-insulin-homa-ir-early-metabolic-markers
Publisher: Velri (https://velri.co/about)
Published: 2026-06-26
Updated: 2026-09-30
Editorial policy: https://velri.co/editorial-policy

HOMA-IR estimates insulin resistance using fasting glucose and insulin. It describes the relationship between those two measurements rather than directly testing how each tissue responds to insulin. Its value depends on reliable samples and careful interpretation. [1][2]

## What insulin resistance means

Insulin helps glucose move from the bloodstream into cells. With insulin resistance, cells respond less effectively. The pancreas may produce more insulin, keeping blood glucose within the usual range for a time. Insulin and glucose therefore describe related but different parts of the process. [3]

A high fasting insulin result can be relevant, but its meaning depends on the glucose measured with it and the clinical circumstances. [3]

## What HOMA-IR adds

The original homeostasis model assessment used fasting glucose and insulin to estimate the body's resting balance between insulin production and insulin resistance. The original research found correlations with more intensive research measurements, while also reporting limited precision. [1]

The model has been used in clinical research and studies of large populations. It allows researchers to estimate insulin resistance from a fasting blood sample, making it simpler to collect than more intensive measurements. Its developers emphasize that useful results depend on the quality of the inputs and how the estimates are interpreted. [2]

## How this differs from diabetes testing

Prediabetes is usually assessed with blood glucose tests such as A1C, fasting plasma glucose or an oral glucose tolerance test. NIDDK notes that direct insulin-resistance testing is primarily used in research. [4]

HOMA-IR can contribute to a specific assessment, but it does not replace the established tests used to diagnose prediabetes or diabetes. [2][4]

For a report containing HOMA-IR, the useful context is why the result was ordered and how it relates to the glucose results. A provider can explain whether it changes the assessment or the next clinical decision. [2][4]

## Sources
[1] Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. (1985). https://pubmed.ncbi.nlm.nih.gov/3899825/
[2] Use and abuse of HOMA modeling. (2004). https://pubmed.ncbi.nlm.nih.gov/15161807/
[3] Insulin in Blood: MedlinePlus Medical Test. https://medlineplus.gov/lab-tests/insulin-in-blood/
[4] Insulin Resistance & Prediabetes - NIDDK. https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/prediabetes-insulin-resistance

## About this information
General health information, not personal medical advice, diagnosis or treatment. A prescription is required and is never guaranteed.
Velri is a brand operated by Velri Management LLC, a Nevada limited liability company. Velri is a non-clinical technology and administrative services company. Velri does not provide medical advice, diagnosis, treatment, or pharmacy services, and does not direct the clinical judgment of any provider.
All medical consultations and prescriptions are provided directly by independent provider groups (Online Medical Care, P.C.; TMD of Kansas, P.A.; TMD of Texas, P.A.; and TMD of CA, PC), by a provider licensed in your state. Velri does not employ providers. A prescription is issued only if a provider determines it is clinically appropriate in their independent medical judgment.
All prescription products are dispensed by independent, licensed pharmacies. Velri does not own, operate, or control any pharmacy and does not dispense medication. You may opt out of using a given provider group or pharmacy at any time.
Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
Velri is cash-pay. We do not bill Medicare, Medicaid, or commercial insurance. Refunds and order problems are addressed in the Terms of Use; your rights under applicable law are not limited. State availability and clinical eligibility apply.
Velri and telehealth are not for medical emergencies. If you are experiencing an emergency, call 911.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Care is available to eligible adults 18 and older in 47 states and D.C., United States only.
Notice of Privacy Practices: https://velri.co/privacy/notice-of-privacy-practices
Terms: https://velri.co/legal/terms
Provider group or pharmacy opt-out help: https://velri.co/contact and https://velri.co/standards#trust-support